My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Oralair 300 IR sublingual tablets



STALLERGENESPA2113/001/002

Main Information

Trade NameOralair 300 IR sublingual tablets
Active SubstancesGrass pollen allergen extract
Dosage FormSublingual tablet
Licence HolderSTALLERGENES
Licence NumberPA2113/001/002

Group Information

ATC CodeV01AA Allergen extracts
V01AA02 grass pollen

Status

License statusAuthorised
Licence Issued19/02/2010
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceBatches of Oralair marketed in Ireland shall be subject to controlled authority batch release in accordance with Article 114.1 of Directive 2001/83/EC as amended.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print